234 related articles for article (PubMed ID: 571358)
21. [Rational hormonal diagnosis of oligomenorrhea].
Weise HC; Moltz L; Bispink G; Leidenberger F
Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):694-700. PubMed ID: 2529165
[TBL] [Abstract][Full Text] [Related]
22. Plasma testosterone and dihydrotestosterone in ovulatory and anovulatory cycles.
Dawood MY; Saxena BB
Am J Obstet Gynecol; 1976 Oct; 126(4):430-5. PubMed ID: 984104
[TBL] [Abstract][Full Text] [Related]
23. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
24. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
25. Hyperprolactinemic anovulatory syndrome.
Bohnet HG; Dahlén HG; Wuttke W; Schneider HP
J Clin Endocrinol Metab; 1976 Jan; 42(1):132-43. PubMed ID: 765352
[TBL] [Abstract][Full Text] [Related]
26. Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women.
Evron S; Shapiro G; Diamant YZ
Fertil Steril; 1981 Oct; 36(4):468-71. PubMed ID: 6793406
[TBL] [Abstract][Full Text] [Related]
27. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
[TBL] [Abstract][Full Text] [Related]
28. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
[TBL] [Abstract][Full Text] [Related]
29. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
30. Endocrine comparison of obese menstruating and amenorrheic women.
Zhang YW; Stern B; Rebar RW
J Clin Endocrinol Metab; 1984 Jun; 58(6):1077-83. PubMed ID: 6427258
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
[TBL] [Abstract][Full Text] [Related]
32. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
[TBL] [Abstract][Full Text] [Related]
33. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.
Fox R; Corrigan E; Thomas PG; Hull MG
Br J Obstet Gynaecol; 1991 Mar; 98(3):294-9. PubMed ID: 1827032
[TBL] [Abstract][Full Text] [Related]
35. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
36. [The value of the GnRH double stimulation test in differentiation of oligo-amenorrhea].
Rossmanith WG; Schramm S; Benz R; Lauritzen C
Gynakol Rundsch; 1991; 31 Suppl 2():331-3. PubMed ID: 1790970
[No Abstract] [Full Text] [Related]
37. [Hyperprolactinemic ovarian insufficiency].
Schneider HP; Bohnet HG
Gynakologe; 1981 Jun; 14(2):104-18. PubMed ID: 6790354
[No Abstract] [Full Text] [Related]
38. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
Ohsawa M; Asai M; Masahashi T; Narita O; Tomoda Y; Matsui N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
[TBL] [Abstract][Full Text] [Related]
39. Plasma hormones in clomiphene citrate therapy.
Wu CH
Obstet Gynecol; 1977 Apr; 49(4):443-8. PubMed ID: 857209
[TBL] [Abstract][Full Text] [Related]
40. Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome.
van Hooff MH; van der Meer M; Lambalk CB; Schoemaker J
Hum Reprod; 1999 Jul; 14(7):1684-9. PubMed ID: 10402368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
